2013 Community Awards Honor University-Industry Experts
Friday, January 18, 2013
Posted by: Angela King
ATLANTA, GA (January 18, 2013) -- Georgia Bio each year recognizes individuals, companies and organizations for significant contributions to Georgia’s life sciences industry with its Georgia Bio Community Awards. The recipients will be honored at the Annual Awards Dinner January 24, 6 pm to 9 pm, at Atlanta’s Fox Theater.
The 2013 recipients are L. Franklin Bost, MBA, IDSA, Professor of the Practice and Executive Director of the Master of Biomedical Innovation & Development Program in the Wallace H. Coulter Dept. of Biomedical Engineering at the Georgia Institute of Technology and Emory University; Barbara D. Boyan, PhD, Professor, Price Gilbert, Jr. Chair in Tissue Engineering, and Associate Dean for Research, College of Engineering at Wallace H. Coulter Dept. of Biomedical Engineering, Georgia Institute of Technology and Emory University; Chris Lepore, Senior Director, State Government Affairs, Worldwide Government Affairs & Policy, Johnson & Johnson; Tina McKeon PhD, Partner, Kilpatrick Townsend & Stockton LLP; and Harold H. Shlevin, PhD, Chief Operating Officer for Galectin Therapeutics Inc.
L. Franklin Bost directed the Biomedical Engineering Capstone Design Program over the past five years and recently developed the Masters of Biomedical Innovation and Development Program. He became a connector between engineering students, clinicians and industry throughout the Atlanta medical community. Mr. Bost has mentored hundreds of design teams,which produced Inventure Prize winners, Georgia Tech Business Plan Competition winners, national student completion winners and company startups. In February, Bost will become the Associate Dean for Innovation and Outreach in the School of Engineering at Virginia Commonwealth University. His impact on students, clinicians and inventors will last well beyond his tenure at Georgia Tech. Mr. Bost was previously President of Porex Surgical Inc., a division of Porex Corporation which was acquired by Stryker Corporation in 2010. Mr. Bost also served on AdvaMed's Technology and Regulatory committee from 1992 to 2006.
Barbara D. Boyan arrived in Atlanta just over 10 years ago to drive research and innovation at Georgia Institute of Technology's Biomedical Engineering Department. Dr. Boyan has brought a strong commitment to commercialization along with experience and connections to the Georgia life science community. Her tenure at Georgia Tech culminated in the Translational Research Institute for Biomedical Engineering (TRIBES) and the Center for Advanced Bioengineering Soldier Survivability (CABSS). Dr. Boyan’s recent roles in bringing together researchers and government funding to champion commercialization include the Atlanta Pediatric Device Consortium (APDC), the Atlanta Clinical and Translational Science Institute (ACTSI) and a seed grant program between Georgia Tech and Children's Healthcare of Atlanta. Dr. Boyan is engaged with several biotech startups and has collaborated with the medical device industry for decades. Dr. Boyan begins a new chapter in her career in January 2013 as Dean of Virginia Commonwealth University's School of Engineering.
Chris Lepore has made a significant contribution in advocating for the interests of the bioscience industry before federal, state and local governmental authorities since he moved to Georgia in 2010. His outstanding influence and community involvement as the chair of the Georgia Bio government affairs committee has led to the establishment of the Georgia Biosciences Organization, an aggressive legislative education effort with Georgia’s state government officials and Congressional delegation. In his role as sponsorship chair for the 2012 Georgia Life Sciences Summit, Mr. Lepore succeeded in exceeding one of the highest sponsorship goals the event has ever had. Additionally, he helped to secure the Johnson & Johnson Family of Companies as a Champion of Georgia Bio. Mr. Lepore serves on the Georgia Bio Board of Directors, Southeast Medical Device Association Board of Directors, and the Metro Atlanta Chamber of Commerce Board of Advisors; he has also served as Vice Chair for the Georgia PhRMA Task Force.
Tina McKeon is that rare combination of scientific expertise, legal acumen and sociability that affords her a broad role in the Georgia life sciences community. She serves as a member of the Georgia Bio and Southeast BIO Board of Directors. Dr. McKeon has helped hundreds of life sciences companies with intellectual property challenges and opportunities through her "day job" in law where she recently joined Kilpatrick Townsend from McKeon, Meunier, Carlin & Curfman. Prior to that, she was a member of the Atlanta office of Fish & Richardson. During her career, Dr. McKeon has contributed her talent and time to the bioscience and medical device community. She is an adjunct professor at Emory Law School and has taught for a number of years in the TI:GER® Program, a collaboration between Georgia Tech and Emory University; she sits on committees with Southeast BIO and Georgia Bio; and she sat on the Steering Committee for the 2009 BIO International Convention. Dr. McKeon has received countless awards throughout her career; most recently she was named the "Atlanta Best Lawyers Patent Law Lawyer of the Year" for 2012 by Best Lawyers, the oldest and most respected peer-review publication in the legal profession. In these roles, she is known throughout the community as a mentor to women in the life sciences. Dr. McKeon has been a leader in helping Georgia Bio expand its membership and improve its programming over the years.
Harold H. Shlevin has been engaged in the Atlanta life sciences community since 1991 when he moved from CIBA-Geigy Pharmaceuticals in New Jersey to Atlanta to help co-found CIBA Vision Ophthalmics as part of CIBA Vision family. Following the formation of Novartis and the move of the CIBA Vision Ophthalmics drug group back to New Jersey, Harold remained in Atlanta and joined Solvay Pharmaceuticals. Harold has contributed greatly to the growing life sciences industry in Georgia, from volunteering for panels and business plan competitions to remaining in Atlanta, after having served as President and CEO of Solvay Pharmaceuticals, USA, to found Tikvah Therapeutics, a development stage company focused on neuroscience. Subsequently Harold spent three years coaching faculty and startups at Georgia Tech's Advanced Technology Development Center (ATDC) and supporting the Georgia Research Alliance's Venturelab program. In October 2012, Dr. Shlevin joined another development stage startup company as COO, Galectin Therapeutics, which relocated from Boston to Atlanta. In addition to his contributions in pharma, startups and academia, Dr. Shlevin has served on the board of directors of several small and large companies, as well as Georgia Bio. He remains extremely accessible and is a powerful mentor and connector in the community.
Georgia Bio (www.gabio.org) is the private, non-profit association whose members include pharmaceutical, biotechnology and medical device companies, medical centers, universities and research institutes, government groups and other business organizations involved in the development of life sciences related products and services.
Note to Editors: Credentialed members of the news media are invited to attend. Registration is complimentary. Please contact Maria Thacker (404-920-2042; email@example.com).